HIV-associated asymmetric lipodystrophy syndrome.


Mr. Editor: Since the introduction of HIV-1 protease inhibitors as components of antiretroviral drug combination regimens, the clinical course of HIV disease and opportunistic infections have changed dramatically. However, paralelly to the virological, immunological and clinical benefit of highly active antiretroviral therapy (HAART) several adverse drug… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics